Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
-
STEALTHGAS INC. Announces the Date for the Release of the First Quarter 2026 Financial and Operating Results, Conference Call and Webcast
-
Vertex to Present at the 46th Annual William Blair Growth Stock Conference
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
-
NuCana Appoints Ian Webster as Chief Financial Officer
-
Cole West Names Chris Winter President of Homebuilding
-
WTW strengthens North America Outsourcing Sales team with senior industry hires
-
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
-
Blue Sky and Sincerely Jules Bring Vintage Style to Academic Planners at Staples
-
ASML reports transactions under its current share buyback program
-
Kalmar Corporation: Share repurchase during week 22
-
Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis
-
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
-
Rapid7 Appoints Wael Mohamed Chief Executive Officer; Corey Thomas to Become Executive Chairman
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 Per Share for June 2026
-
Vedder Adds Depth to Washington DC Office With Addition of Life Sciences Attorney Melissa Gilmore
-
Aldebaran Announces Execution of Arrangement Agreement for Spin-Out of Centauri Minerals Inc.
-
Canadian Life Companies Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
-
Cognition Therapeutics Participating in Upcoming Investor Conferences
-
Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project
-
Dividend 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Financial 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology
-
North American Financial 15 Split Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Nayax Launches AI-Powered Product Discovery for Retailers
-
Canadian Banc Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Dividend 15 Split Corp. II Announces TSX Acceptance of Normal Course Issuer Bid
-
SL Green Announces the Sale of 10 East 53rd Street
-
Belo Sun Announces Corporate Update
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
-
DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS
-
Anterix Sets Fourth Quarter Fiscal 2026 Earnings Conference Call for Thursday, June 11, at 9:00 a.m. ET
-
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
-
XCharge Appoints Albina Iljasov as Co-Chief Executive Officer
-
TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics
-
BriaCell Presents Positive Clinical Data at ASCO 2026
-
HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs
-
Athene Announces Key Leadership Appointment
-
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
-
Vireo Growth Inc. Announces Share Consolidation
-
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Mattr Appoints New Director
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
-
Otherwander Opens in the Heart of Soho, London
